Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bliss GVS Pharma Limited Share Issue/Capital Change 2021

Nov 18, 2021

61284_rns_2021-11-18_f50497a9-7944-457e-8d67-af96e602aa00.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

BLISS GVS PHARMA LTD.

November 18, 2021

To To
The Manager, Listing Department The General Manager, Listing Department
National Stock Exchange of India Ltd. BSE Limited
Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers,
Bandra-Kurla Complex, Bandra (East), Dalal Street,
Mumbai- 400 051 Mumbai- 400 001
Symbol: BLISSGVS Scrip Code: 506197

Dear Sir/ Madam,

Subject: Allotment of Shares under Bliss GVS Pharma Limited -Employee Stock Options Plan 2019

We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on November 18, 2021 has approved the allotment of 1,69,000 equity shares of face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan 2019 ('Bliss GVS ESOP-2019')

Consequent to the aforesaid allotment, Issued, subscribed & paid-up share capital of the Company has increased as under:

From To
10 ,35 ,08, 922 equity shares of Re. 1/-
each
10,36,77,922 equity shares of Re. 1/- each
aggregating Rs. 10,35,08,922 /- aggregating Rs. 10,36,77,922 /-

In terms of Regulation lO(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015 the details of shares allotted as above are given in' Annexure-I';

Thanking you. Yours Faithfully,

Plot No. 10, 11 & 12, Survey No. 38/1, Dewan Udyog Nagar, Aliyali Village, Tai. & Dist. Palghar - 401 404. Tel. (+91) (02525) 252713 • Fax: (+91) (02525) 255257. ·Email: [email protected] Factory:

'Annexure - I'

Regulation lO(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

Company
and
Name
address
of
Bliss GVS Pharma Limited
Registered Office Add:
Hyde Park,
Sakivihar
Road,
102,
Andheri (East), Mumbai - 400072
Name of the Stock Exchanges
on which
BSE Limited
the Company's shares are listed The National
Stock
Exchange
of India
Limited
Filing date of the statement referred in 14/02/2
020
regulation lO(b) of the SEBI (Share Based
Employee Benefits) Regulations, 2014 read
(Share
the SEBI
Employee
with
Based
Benefits and Sweat Equity) Regulations,
2021 with the recognized Stock Exchange
Filing Number, if any Application No:
BSE -106063
NSE- 23188
In-Principle Approval Letter:
BSE: DCS/FL/DS/ESOP-IP
/542/2019-20
dated February 27, 2020
NSE: NSE/LIST/23188
dated March 04,
2020
Title of the Scheme pursuant to which Limited-Employee
Pharma
Bliss
GVS
shares are issued, if any Stock Option Plan 2019
Kind of security to be listed Equity Shares
Par value of the shares Re. 1/- Per Share
Date of issue of shares November 18, 2021
Number of shares issued 1,69,000
Share Certificate No., if applicable Not Applicable
share,
Distinctive
number
the
if
of
to
10,35,08,923
(both
10,36,77,922
applicable inclusive)
ISIN Number of the shares if issued in INE416D01022
Demat

Rs. 43 / - per share
Exercise price per share
Premium per share
Rs. 42/ - per share
Total Issued shares after this issue
10,36,77,922
Rs. 10,36,77,922/
Total Issued share capital after this issue
-
Details of any lock-in on the shares as per
Lock in for a period of 6 (six) months from
the date of allotment of Equity Shares.
Date of expiry of lock-in
May 17, 2022
Whether shares identical in all respects to
All equity shares of the Company allotted
if not, when will they
pursuant to exercise of stock options shall
shares
existing
rank pari-passu with the existing equity
become identical?
shares of the Company
Details of listing fees, if payable
Not applicable

Relevant disclosures as per SEBI circular CIR/CFD/CMD/4/2015 dated September 9, 2015

Options Vested 6,90,250 Equity Shares
which
option
within
may
Time
be
Within a period of 6 (Six) months from the
exercised date of vesting of such options.
Options exercised 1,69,000 Equity Shares
Money realized by exercise of options Rs. 72,67,000/-
The total
number
of shares
arising
as
1,69,000 Equity Shares
result of exercise of option
Options lapsed 1,59,000 Equity Shares
Diluted earnings per share pursuant to Rs. 6.51/
-per
share
of equity
shares
exercise
issue
on
of
options
Whether the scheme is in terms of SEBI Yes
Benefits
Employee
(Share
Based
and
Sweat Equity) Regulations, 2021

For Bliss GVS Pharma Limited